Corrigendum: Guanxin Danshen formulation protects against myocardial ischemia reperfusion injury-induced left ventricular remodeling by upregulating estrogen receptor β

Authors :: Xuehong Deng
Xiaoyan Xing
Guibo Sun
Xudong Xu
Haifeng Wu
Guang Li
Xiaobo Sun
Source :: Frontiers in Pharmacology, Vol 15 (2024)
Publication Year :: 2024
Publisher :: Frontiers Media S.A., 2024.

Subjects :: Guanxin Danshen formula
myocardial ischemia reperfusion injury
ventricular remodeling
network pharmacology
estrogen receptor β
PI3K/Akt
Therapeutics. Pharmacology
RM1-950

Full Text Access

Tools